Paraoxonase and arylesterase activities, lipid profile, and oxidative damage in experimental ischemic colitis model

Gastroenterology Research and Practice

Volumn , Issue , 2012, Pages

  Unal, Ethem ^a   Eris, Cengiz ^a   Kaya, Bülent ^b   Uzun, Hafize ^c   Cavdar, Faruk ^a   Yildar, Murat ^d   Kiziler, Ali Riza ^e   Aydemir, Birsen ^f   Gunes, Pembegul ^a   Kutanis, Riza ^g   Titiz, Izzet ^a  

^a HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b FATIH SULTAN MEHMET TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d BALIKESIR UNIVERSITY   (Turkey)

^e NAMIK KEMAL UNIVERSITY   (Turkey)

^f SAKARYA UNIVERSITY   (Turkey)

^g BAGCILAR TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLESTERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEVASCULARIZATION; DISEASE MARKER; ENZYME ACTIVITY; HISTOPATHOLOGY; ISCHEMIC COLITIS; LAPAROTOMY; MALE; MICROSCOPY; NONHUMAN; OXIDATIVE STRESS; RAT; RETROSPECTIVE STUDY; SHAM PROCEDURE; STUDENT T TEST;

EID: 84871398670     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2012/979506     Document Type: Article

References (17)

1. Huguier M., Barrier A., Boelle P. Y., Houry S., Lacaine F., Ischemic colitis. American Journal of Surgery 2006 192 5 679 684 2-s2.0-33750380969 10.1016/j.amjsurg.2005.09.018 (Pubitemid 44634329)
2. Scharff J. R., Longo W. E., Vartanian S. M., Jacobs D. L., Bahadursingh A. N., Kaminski D. L., Stellato T. A., Talamonti M. S., Velasco J. M., Ischemic colitis: spectrum of disease and outcome. Surgery 2003 134 4 624 630 2-s2.0-0242550905 10.1016/S0039-6060(03)00308-8 (Pubitemid 37411969)
3. Alapati S. V., Mihas A. A., When to suspect ischemic colitis: why is this condition so often missed or misdiagnosed? Postgraduate Medicine 1999 105 4 177 187 2-s2.0-0033047429 (Pubitemid 29185781)
4. Guttormson N. L., Bubrick M. P., Mortality from ischemic colitis. Diseases of the Colon and Rectum 1989 32 6 469 472 2-s2.0-0024344944 (Pubitemid 19148674)
5. Thomson A., Hemphill D., Jeejeebhoy K. N., Oxidative stress and antioxidants in intestinal disease. Digestive Diseases 1998 16 3 152 158 2-s2.0-0032059117 (Pubitemid 128529227)
6. Koga K., Ishitobi Y., Kawashima S., Taniguchi M., Murakami M., Membrane permeability and antipyrine absorption in a rat model of ischemic colitis. International Journal of Pharmaceutics 2004 286 1-2 41 52 2-s2.0-6944237662 10.1016/j.ijpharm.2004.07.032 (Pubitemid 39410472)
7. Tsuzura S., Ikeda Y., Suehiro T., Ota K., Osaki F., Arii K., Kumon Y., Hashimoto K., Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism 2004 53 3 297 302 2-s2.0-1842454052 10.1016/j.metabol.2003. 10.009 (Pubitemid 38684688)
8. Santanam N., Parthasarathy S., Aspirin is a substrate for paraoxonase-like activity: implications in atherosclerosis. Atherosclerosis 2007 191 2 272 275 2-s2.0-33947252213 10.1016/j.atherosclerosis.2006.05.027 (Pubitemid 46415635)
9. Hiiemae K., Rozmiarek H., Williams J. F., LeBeau J. E., Ross M., Report of a panel discussion on how to run an effective Animal Care and Use Committee. Laboratory Animal Science Chicago 1987 37 39 44 2-s2.0-0023075928
10. Buege J. A., Aust S. D., Microsomal lipid peroxidation. Methods in Enzymology 1978 52 302 310 2-s2.0-0017872475 10.1016/S0076-6879(78)52032-6
11. Yao T., Iwashita A., Hoashi T., Matsui T., Sakurai T., Arima S., Ono H., Schlemper R. J., Phlebosclerotic colitis: value of radiography in diagnosis-report of three cases. Radiology 2000 214 1 188 192 2-s2.0-0033966846 (Pubitemid 30019889)
12. Jaouad L., Milochevitch C., Khalil A., PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity. Free Radical Research 2003 37 1 77 83 2-s2.0-0037245337 10.1080/ 1071576021000036614 (Pubitemid 36124333)
13. Nguyen S. D., Sok D. E., Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action. Free Radical Research 2003 37 12 1319 1330 2-s2.0-0344875683 10.1080/1071-5760310001621351 (Pubitemid 37441715)
14. Mackness B., Durrington P. N., Boulton A. J. M., Hine D., Mackness M. I., Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls. European Journal of Clinical Investigation 2002 32 4 259 264 2-s2.0-0036995784 10.1046/j.1365-2362.2002.00977.x (Pubitemid 36216591)
15. Unal E., Uzun H., Kusaslan R., Dogan M., Genc H., Gunes P., Titiz I., Serum paraoxonase (a high-density lipoprotein-associated lipophilic antioxidant) activity and lipid profile in experimental acute pancreatitis. Pancreas 2005 31 1 84 87 2-s2.0-21344471085 10.1097/01.mpa.0000168227.74203.e4 (Pubitemid 40911508)
16. Granér M., James R. W., Kahri J., Nieminen M. S., Syvänne M., Taskinen M. R., Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease. Journal of the American College of Cardiology 2006 47 12 2429 2435 2-s2.0-33744993389 10.1016/j.jacc.2006.01.074 (Pubitemid 43866362)
17. Manresa J. M., Zamora A., Tomás M., Sentí M., Fitó M., Covas M. I., Alcántara M., Latorre G., Escurriol V., Domingues S., Marrugat J., Relationship of classical and non-classical risk factors with genetic variants relevant to coronary heart disease. European Journal of Cardiovascular Prevention and Rehabilitation 2006 13 5 738 744 2-s2.0-33749011673 10.1097/01.hjr.0000224484.80349.3f (Pubitemid 44454846)